Array Comparative Genomic Hybridization in Pediatric Acute Leukemias
- 12 June 2013
- journal article
- research article
- Published by Taylor & Francis in Pediatric Hematology and Oncology
- Vol. 30 (8) , 677-687
Abstract
Array comparative genomic hybridization has proven to be a very powerful tool in searching for new biomarkers which can find an application in clinical practise. CGH-array technology is satisfying in almost every possible way. It is highly specific, sensitive, simple, and relatively cheap. Thus, this modern method meets the demands of clinical application. An increasing knowledge about molecular pathways and pathologic genome alterations in acute leukemias enable to define unequivocal diagnosis, prognosis and to predict a response to individual compatible therapy. This review shows a various application of CGH-array in pediatric acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).Keywords
This publication has 36 references indexed in Scilit:
- Outcomes after Induction Failure in Childhood Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 2012
- Genomic Imbalances Are Confined to Non-Proliferating Cells in Paediatric Patients with Acute Myeloid Leukaemia and a Normal or Incomplete KaryotypePLOS ONE, 2011
- Chromosomal Minimal Critical Regions in Therapy-Related Leukemia Appear Different from Those of De Novo Leukemia by High-Resolution aCGHPLOS ONE, 2011
- The TLX1 oncogene drives aneuploidy in T cell transformationNature Medicine, 2010
- Absence of Biallelic TCRγ Deletion Predicts Early Treatment Failure in Pediatric T-Cell Acute Lymphoblastic LeukemiaJournal of Clinical Oncology, 2010
- Different molecular mechanisms causing 9p21 deletions in acute lymphoblastic leukemia of childhoodHuman Genetics, 2009
- A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification studyThe Lancet Oncology, 2009
- A decade of genome-wide gene expression profiling in acute myeloid leukemia: flashback and prospectsBlood, 2009
- New technologies for diagnosing pediatric tumorsExpert Opinion on Medical Diagnostics, 2008
- Whole genome scanning as a cytogenetic tool in hematologic malignanciesBlood, 2008